News

Corona/COVID 19 - INNO4COV-19 - "Innovation hub" project (1st deadline on 30 November 2020)

Published on | 5 years ago

Programmes
ICT NMBP Health

INNO4COV-19 OPEN CALL - Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance

Are you working for a company active in healthcare,  medicine, biotech, biopharma, and/or IT-related topics (e.g. robotics, automation, electronics, nanotech, etc)? Then have a look at this accessible funding scheme (up to 100k€ subsidy). 

Submission deadlines in November 2020, March 2021 and May 2021.

INNO4COV-19 at a Glance

Create a “lab-to-fab” platform and collaboration resource to enable companies and reference laboratories to develop and implement innovative technologies to fight COVID-19.

Website: www.inno4cov19.eu

The INNO4COV-19 Project aims to support the full development to market uptake of technologies at TRL6-7 or higher. It Provides funding to third parties to archive the desiderated objectives.

Eligibility criteria

  • Companies or small consortia of companies established in one of the EU Member States or H2020 associated countries.
  • The sectors of focus may include healthcare / medicine / biotech / biopharma, and IT-related topics (e.g. robotics, automation, electronics, nanotech, etc).

What they offer

  • Financial support - Up to EUR 100,000 (100% of the total cost of the project)
  • Tailored support - Guidance from a network of experts at a technical, business and regulatory level for bringing your innovation to the market
  • Access to specific facilities and infrastructure - Providing added value to your innovations
  • Media exposure - Highlights through our network

Key dates

The applications will be considered in three different rounds.

  • NOVEMBER 2020 ROUND - Deadline: 30/11/2020 – Funding decision: +40days
  • MARCH 2021 ROUND - Deadline: 31/03/2021 – Funding decision: +40days
  • May 2021 ROUND - Deadline: 31/05/2021 – Funding decision: +40days

More information on the website of the call: www.inno4cov19.eu/open-call

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1882 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.